Publishing Service

Polishing & Checking

Journal of Zhejiang University SCIENCE B

ISSN 1673-1581(Print), 1862-1783(Online), Monthly

Lycium barbarum polysaccharides ameliorate canine acute liver injury by reducing oxidative stress, protecting mitochondrial function, and regulating metabolic pathways

Abstract: The development of acute liver injury can result in liver cirrhosis, liver failure, and even liver cancer, yet there is currently no effective therapy for it. The purpose of this study was to investigate the protective effect and therapeutic mechanism of Lycium barbarum polysaccharides (LBPs) on acute liver injury induced by carbon tetrachloride (CCl4). To create a model of acute liver injury, experimental canines received an intraperitoneal injection of 1 mL/kg of CCl4 solution. The experimental canines in the therapy group were then fed LBPs (20 mg/kg). CCl4-induced liver structural damage, excessive fibrosis, and reduced mitochondrial density were all improved by LBPs, according to microstructure data. By suppressing Kelch-like epichlorohydrin (ECH)-associated protein 1 (Keap1), promoting the production of sequestosome 1 (SQSTM1)/p62, nuclear factor erythroid 2-related factor 2 (Nrf2), and phase II detoxification genes and proteins downstream of Nrf2, and restoring the activity of anti-oxidant enzymes like catalase (CAT), LBPs can restore and increase the antioxidant capacity of liver. To lessen mitochondrial damage, LBPs can also enhance mitochondrial respiration, raise tissue adenosine triphosphate (ATP) levels, and reactivate the respiratory chain complexes I‒V. According to serum metabolomics, the therapeutic impact of LBPs on acute liver damage is accomplished mostly by controlling the pathways to lipid metabolism. 9-Hydroxyoctadecadienoic acid (9-HODE), lysophosphatidylcholine (LysoPC/LPC), and phosphatidylethanolamine (PE) may be potential indicators of acute liver injury. This study confirmed that LBPs, an effective hepatoprotective drug, may cure acute liver injury by lowering oxidative stress, repairing mitochondrial damage, and regulating metabolic pathways.

Key words: Acute liver injury; Oxidative stress; Mitochondrial dysfunction; Metabolomics; Lycium barbarum polysaccharides

Chinese Summary  <93> 枸杞多糖通过降低氧化应激、保护线粒体功能和调节代谢途径改善犬急性肝损伤

黄健佳1,2,白雨曼1,谢文婷1,王荣梅3,邱文粤1,周水莲1,唐兆新1,廖建昭1,苏荣胜1
1华南农业大学兽医学院,中国广州,510642
2广州医药研究总院有限公司,中国广州,510240
3韶关大学生物与农业学院,中国韶关,512005
概要:急性肝损伤的发展可导致肝硬化、肝衰竭,甚至肝癌,但目前尚无有效的治疗方法。本研究旨在探讨枸杞多糖(LBPs)对四氯化碳(CCl4)诱导的急性肝损伤的保护作用及其治疗机制。为了建立急性肝损伤模型,以1 mL/kg的剂量对实验犬进行CCl4溶液的腹腔注射。然后给治疗组的实验犬喂食枸杞多糖(20 mg/kg)。微观结果显示,CCl4诱导的肝脏结构损伤、过度纤维化和线粒体密度降低都可以通过给予LBPs得到改善。LBPs可以通过抑制Kelch样ECH相关蛋白1(Keap1),促进蛋白(p62)、核因子E2相关因子2(Nrf2)和Nrf2下游的II期解毒基因和蛋白的产生,以及恢复过氧化氢酶(CAT)等抗氧化酶的活性,恢复并增加肝脏的抗氧化能力。LBPs还可以增强线粒体呼吸能力,提高组织ATP水平,以及重新激活呼吸链复合体I-V以减轻线粒体的损伤。血清代谢组学结果显示,LBPs对急性肝损伤的治疗作用主要通过控制脂质代谢途径实现。9-羟基十八碳二烯酸(9-HODE)、溶血磷脂酰胆碱(LPC)和磷脂酰乙醇胺(PE)可能是急性肝损伤的潜在标志物。这项研究证实,LBPs是一种有效的保肝药物,可以通过降低氧化应激、修复线粒体损伤和调节代谢途径来治疗急性肝损伤。

关键词组:急性肝损伤;氧化应激;线粒体功能障碍;代谢组学;枸杞多糖


Share this article to: More

Go to Contents

References:

<Show All>

Open peer comments: Debate/Discuss/Question/Opinion

<1>

Please provide your name, email address and a comment





DOI:

10.1631/jzus.B2200213

CLC number:

Download Full Text:

Click Here

Downloaded:

925

Download summary:

<Click Here> 

Downloaded:

375

Clicked:

1370

Cited:

0

On-line Access:

2023-02-05

Received:

2022-04-11

Revision Accepted:

2022-09-25

Crosschecked:

2023-02-09

Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou 310027, China
Tel: +86-571-87952276; Fax: +86-571-87952331; E-mail: jzus@zju.edu.cn
Copyright © 2000~ Journal of Zhejiang University-SCIENCE